Does DABRAFENIB Cause Recurrent cancer? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Recurrent cancer have been filed in association with DABRAFENIB (Tafinlar). This represents 0.2% of all adverse event reports for DABRAFENIB.
38
Reports of Recurrent cancer with DABRAFENIB
0.2%
of all DABRAFENIB reports
2
Deaths
7
Hospitalizations
How Dangerous Is Recurrent cancer From DABRAFENIB?
Of the 38 reports, 2 (5.3%) resulted in death, 7 (18.4%) required hospitalization, and 1 (2.6%) were considered life-threatening.
Is Recurrent cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does DABRAFENIB Cause?
Pyrexia (3,788)
Death (2,740)
Malignant neoplasm progression (1,667)
Fatigue (1,328)
Nausea (1,300)
Chills (1,235)
Rash (1,078)
Vomiting (907)
Diarrhoea (901)
Headache (697)
What Other Drugs Cause Recurrent cancer?
NIRAPARIB (776)
IMATINIB (237)
CYCLOPHOSPHAMIDE (143)
TRASTUZUMAB (121)
CAPECITABINE (108)
PEMBROLIZUMAB (107)
RITUXIMAB (99)
DOXORUBICIN (97)
OCTREOTIDE (95)
METHOTREXATE (81)
Which DABRAFENIB Alternatives Have Lower Recurrent cancer Risk?
DABRAFENIB vs DABRAFENIB\TRAMETINIB
DABRAFENIB vs DACARBAZINE
DABRAFENIB vs DACLATASVIR
DABRAFENIB vs DACLIZUMAB
DABRAFENIB vs DACOMITINIB